ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
2 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
1 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix completes $175M placement and launches $25M SPP
|
|
89zirconium
|
41 |
14K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
41
|
14K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
89zirconium vs 89zirconiium
|
|
89zirconium
|
17 |
6.3K |
0 |
23/07/22 |
23/07/22 |
ASX - By Stock
|
17
|
6.3K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
2 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
119
|
32K
|
2
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
110K |
1 |
22/07/22 |
22/07/22 |
Charts
|
338
|
110K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Recommencement of ZIRCON Phase III Trial Recruitment in EU
|
|
89zirconium
|
4 |
2.0K |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
4
|
2.0K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
34
|
8.7K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
34
|
8.7K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
1 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
34
|
8.7K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
How big will 177Lu - PSMA be?
|
|
89zirconium
|
28 |
11K |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
28
|
11K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
110K |
0 |
22/07/22 |
22/07/22 |
Charts
|
338
|
110K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
0 |
22/07/22 |
22/07/22 |
ASX - By Stock
|
34
|
8.7K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
110K |
0 |
22/07/22 |
22/07/22 |
Charts
|
338
|
110K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
110K |
0 |
22/07/22 |
22/07/22 |
Charts
|
338
|
110K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
34
|
8.7K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
34
|
8.7K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Trading Halt
|
|
89zirconium
|
36 |
15K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
36
|
15K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
1 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
0 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
2 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Appendix 4C and Activities Report for June 2022 Quarter
|
|
89zirconium
|
119 |
32K |
3 |
21/07/22 |
21/07/22 |
ASX - By Stock
|
119
|
32K
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Forecasting Quarterly Sales Figures
|
|
89zirconium
|
64 |
16K |
0 |
20/07/22 |
20/07/22 |
ASX - By Stock
|
64
|
16K
|
0
|
|
Charts
|
TLX |
Re:
2022 CHART THREAD
|
|
89zirconium
|
338 |
110K |
0 |
20/07/22 |
20/07/22 |
Charts
|
338
|
110K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Zircon Kidney Cancer Imaging Study completes Enrollment
|
|
89zirconium
|
34 |
8.7K |
0 |
19/07/22 |
19/07/22 |
ASX - By Stock
|
34
|
8.7K
|
0
|
|